Phenytoin May Offer Neuroprotection to Patients With Optic NeuritisFebruary 29, 2016Multiple Sclerosis
Stem cell therapy for MS: Steady progress but not ready for general useFebruary 28, 2016Multiple Sclerosis
Brain atrophy may be a clinically relevant measure in PPMS: Data from INFORMSFebruary 26, 2016Multiple Sclerosis
VIDEO: MS stem cell therapy research progresses, including oligodendrocyte progenitor trialFebruary 24, 2016Multiple Sclerosis
Ocrelizumab subanalysis hints at better efficacy with active inflammatory lesionsFebruary 24, 2016Multiple Sclerosis